Clinical Trials Directory

Trials / Completed

CompletedNCT01600833

The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)

To Association of Serum Ferrtin and Homocysteine Levels With Insulin Resistence and Metabolic Syndrome in Women With Polycystic Ovary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
539 (actual)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the association of serum ferritin and homocysteine levels with insulin resistance and metabolic syndrome in women with polycystic ovary syndrome The polycystic ovary syndrome (PCOS) is a common endocrine disease, affecting 5-10% of women with reproductive age. Insulin resistance and metabolic disturbance are well-known long-term consequence of women with PCOS. Recent evidence suggests that increased body iron might be involved in the pathogenesis of insulin-resistance disorders, furthermore, hyperhomocysteinemia is associated with an increased risk of atherosclerotic and thromboembolic disorder. The investigators plan to retrospectively review the medical records of female patients who visited the Reproductive Endocrinology Clinic at the Wan Fang Medical Center at Taipei Medical University from Jan 1, 2008, to November 30, 2011.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-05-17
Last updated
2013-11-07

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01600833. Inclusion in this directory is not an endorsement.